KSA veterinary neurodegenerative disease diagnostics market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

The KSA Veterinary Neurodegenerative Disease Diagnostics Market is worth USD 6 million, fueled by pet ownership growth, tech advances, and regulations like the 2023 Veterinary Establishments Regulation.

Region:Middle East

Author(s):Rebecca

Product Code:KRAC9681

Pages:98

Published On:November 2025

About the Report

Base Year 2024

KSA Veterinary Neurodegenerative Disease Diagnostics Market Overview

  • The KSA Veterinary Neurodegenerative Disease Diagnostics Market is valued at USD 6 million, based on a five-year historical analysis. This market size reflects the segment’s specialized position within the broader Saudi veterinary diagnostics market, which is valued at over USD 125 million. Growth is primarily driven by rising pet ownership, increased recognition of neurodegenerative conditions in companion animals, advances in diagnostic imaging and biomarker testing, and heightened awareness among pet owners regarding animal health. The sector is further supported by the expansion of veterinary healthcare infrastructure and the increasing demand for specialized diagnostic services tailored to neurological disorders in animals .
  • Key cities such as Riyadh, Jeddah, and Dammam continue to dominate the market due to their advanced veterinary infrastructure and higher density of veterinary clinics and hospitals. These urban centers are home to a significant and growing population of pet owners who are investing in preventive and specialty healthcare for their animals, thereby driving demand for neurodegenerative disease diagnostics .
  • The “Veterinary Establishments Regulation, 2023” issued by the Saudi Ministry of Environment, Water and Agriculture mandates that all licensed veterinary clinics must maintain access to advanced diagnostic tools, including those for neurodegenerative diseases. The regulation covers operational standards, equipment requirements, and compliance inspections, aiming to enhance the quality of veterinary care and ensure timely diagnosis and treatment for companion animals across the country .
KSA Veterinary Neurodegenerative Disease Diagnostics Market Size

KSA Veterinary Neurodegenerative Disease Diagnostics Market Segmentation

By Type:The market is segmented into Diagnostic Imaging, Biomarker Testing, Genetic Testing, Neurological Assessments, and Laboratory-based Assays. Diagnostic Imaging remains the leading sub-segment, accounting for the largest market share due to its essential role in accurately diagnosing neurodegenerative conditions in animals. The adoption of advanced imaging modalities such as MRI and CT scans is increasing in Saudi veterinary practices, enabling earlier and more precise detection of neurological disorders. The growing demand for minimally invasive, high-resolution diagnostic solutions among pet owners is accelerating the uptake of these technologies .

KSA Veterinary Neurodegenerative Disease Diagnostics Market segmentation by Type.

By End-User:The end-user segmentation comprises Veterinary Clinics, Animal Hospitals, Veterinary Diagnostic Laboratories, Research Institutions, Pet Owners, and Others. Veterinary Clinics are the dominant end-user segment, reflecting their accessibility and the increasing number of pet owners seeking regular and preventive health check-ups for their animals. The shift toward preventive healthcare and early intervention in pets has led to a rise in diagnostic testing volumes in clinics, reinforcing their leading position in the market .

KSA Veterinary Neurodegenerative Disease Diagnostics Market segmentation by End-User.

KSA Veterinary Neurodegenerative Disease Diagnostics Market Competitive Landscape

The KSA Veterinary Neurodegenerative Disease Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as IDEXX Laboratories, Inc., Zoetis Inc., Neogen Corporation, Virbac S.A., Heska Corporation, Vetoquinol S.A., Abaxis (a Zoetis company), Elanco Animal Health Incorporated, Boehringer Ingelheim Animal Health, Antech Diagnostics, Inc., PetDx, ACUVET Biotech, Avacta Animal Health Limited, National Veterinary Diagnostic Laboratory (Saudi Arabia), Life Diagnostics, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

IDEXX Laboratories, Inc.

1983

Westbrook, Maine, USA

Zoetis Inc.

2012

Parsippany, New Jersey, USA

Neogen Corporation

1982

Lansing, Michigan, USA

Virbac S.A.

1968

Carros, France

Heska Corporation

1988

Loveland, Colorado, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (KSA Veterinary Diagnostics Segment)

Market Penetration Rate (KSA, by Diagnostic Modality)

Number of Veterinary Diagnostic Tests Offered (Neurodegenerative Focus)

R&D Investment as % of Revenue

Product Innovation Rate (New Launches/Year)

KSA Veterinary Neurodegenerative Disease Diagnostics Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Neurodegenerative Diseases in Pets:The rise in neurodegenerative diseases among pets, such as canine cognitive dysfunction, is alarming, with estimates indicating that approximately 15% of dogs over the age of 8 are affected. This growing prevalence necessitates advanced diagnostic solutions, driving demand in the KSA market. The total pet population in Saudi Arabia is around 2.7 million, with a significant portion being dogs and cats, further amplifying the need for effective diagnostics.
  • Advancements in Diagnostic Technologies:The veterinary diagnostics sector is witnessing rapid technological advancements, particularly in imaging and biomarker identification. For instance, the introduction of MRI and CT scans in veterinary practices has increased by 35% over the past five years. These innovations enhance diagnostic accuracy and speed, making them essential tools for veterinarians in KSA, thereby propelling market growth as clinics adopt these technologies to improve patient outcomes.
  • Rising Pet Ownership and Spending on Veterinary Care:Pet ownership in Saudi Arabia has surged, with over 65% of households owning at least one pet. This trend correlates with increased spending on veterinary care, which reached approximately SAR 1.5 billion in future. As pet owners become more willing to invest in their pets' health, the demand for specialized diagnostic services for neurodegenerative diseases is expected to rise, further stimulating market growth in the region.

Market Challenges

  • High Cost of Advanced Diagnostic Tools:The financial burden associated with advanced diagnostic tools poses a significant challenge in the KSA market. For instance, MRI machines can cost upwards of SAR 1.2 million, making them inaccessible for many veterinary clinics. This high cost limits the availability of cutting-edge diagnostic services, hindering the overall growth of the veterinary neurodegenerative disease diagnostics market in the region.
  • Limited Availability of Trained Veterinary Professionals:The shortage of trained veterinary professionals in Saudi Arabia is a pressing issue, with only about 5,500 licensed veterinarians available for a growing pet population. This scarcity affects the quality of care and the implementation of advanced diagnostic techniques. As a result, the market faces challenges in meeting the increasing demand for specialized neurodegenerative disease diagnostics, impacting overall service delivery.

KSA Veterinary Neurodegenerative Disease Diagnostics Market Future Outlook

The future of the KSA veterinary neurodegenerative disease diagnostics market appears promising, driven by technological advancements and increasing pet ownership. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency, while the growth of telemedicine will facilitate remote consultations. Additionally, as pet owners prioritize preventive healthcare, the demand for innovative diagnostic solutions will likely rise, creating a dynamic environment for market expansion and improved animal health outcomes.

Market Opportunities

  • Expansion of Veterinary Clinics and Hospitals:The establishment of new veterinary clinics and hospitals in urban areas presents a significant opportunity for the diagnostics market. With over 250 new clinics projected to open in the next two years, there will be increased demand for advanced diagnostic tools and services, enhancing access to neurodegenerative disease diagnostics for pet owners across KSA.
  • Development of Innovative Diagnostic Solutions:There is a growing opportunity for companies to develop innovative diagnostic solutions tailored to neurodegenerative diseases in pets. With an estimated investment of SAR 600 million in research and development expected in future, advancements in biomarker research and genetic testing can lead to more effective diagnostics, addressing the specific needs of veterinarians and pet owners alike.

Scope of the Report

SegmentSub-Segments
By Type

Diagnostic Imaging (MRI, CT, X-ray)

Biomarker Testing (Protein, Enzyme, Genetic Markers)

Genetic Testing (DNA, RNA-based Assays)

Neurological Assessments (Behavioral, Cognitive Tests)

Laboratory-based Assays

By End-User

Veterinary Clinics

Animal Hospitals

Veterinary Diagnostic Laboratories

Research Institutions

Pet Owners

Others

By Animal Type

Dogs

Cats

Horses

Exotic Pets

Livestock

Others

By Diagnostic Method

Blood Tests

Imaging Techniques (MRI, CT, X-ray)

Neurological Evaluations

Biopsy Procedures

Molecular Diagnostics

Others

By Distribution Channel

Direct Sales

Online Sales

Distributors

Veterinary Conferences and Trade Shows

Others

By Region

Central Region

Eastern Region

Western Region

Southern Region

By Policy Support

Government Subsidies

Tax Incentives

Research Grants

Regulatory Support

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Environment, Water and Agriculture)

Veterinary Diagnostic Laboratories

Animal Health Product Manufacturers

Veterinary Clinics and Hospitals

Pharmaceutical Companies

Animal Welfare Organizations

Trade Associations in Veterinary Medicine

Players Mentioned in the Report:

IDEXX Laboratories, Inc.

Zoetis Inc.

Neogen Corporation

Virbac S.A.

Heska Corporation

Vetoquinol S.A.

Abaxis (a Zoetis company)

Elanco Animal Health Incorporated

Boehringer Ingelheim Animal Health

Antech Diagnostics, Inc.

PetDx

ACUVET Biotech

Avacta Animal Health Limited

National Veterinary Diagnostic Laboratory (Saudi Arabia)

Life Diagnostics, Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. KSA Veterinary Neurodegenerative Disease Diagnostics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 KSA Veterinary Neurodegenerative Disease Diagnostics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. KSA Veterinary Neurodegenerative Disease Diagnostics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of neurodegenerative diseases in pets
3.1.2 Advancements in diagnostic technologies
3.1.3 Rising pet ownership and spending on veterinary care
3.1.4 Growing awareness about animal health and wellness

3.2 Market Challenges

3.2.1 High cost of advanced diagnostic tools
3.2.2 Limited availability of trained veterinary professionals
3.2.3 Regulatory hurdles in product approvals
3.2.4 Competition from alternative diagnostic methods

3.3 Market Opportunities

3.3.1 Expansion of veterinary clinics and hospitals
3.3.2 Development of innovative diagnostic solutions
3.3.3 Collaborations with research institutions
3.3.4 Increasing demand for preventive healthcare services

3.4 Market Trends

3.4.1 Integration of AI and machine learning in diagnostics
3.4.2 Shift towards personalized veterinary medicine
3.4.3 Growth of telemedicine in veterinary care
3.4.4 Rising focus on pet insurance and health plans

3.5 Government Regulation

3.5.1 Veterinary product registration requirements
3.5.2 Compliance with animal welfare standards
3.5.3 Guidelines for clinical trials and studies
3.5.4 Regulations on import and export of diagnostic tools

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. KSA Veterinary Neurodegenerative Disease Diagnostics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. KSA Veterinary Neurodegenerative Disease Diagnostics Market Segmentation

8.1 By Type

8.1.1 Diagnostic Imaging (MRI, CT, X-ray)
8.1.2 Biomarker Testing (Protein, Enzyme, Genetic Markers)
8.1.3 Genetic Testing (DNA, RNA-based Assays)
8.1.4 Neurological Assessments (Behavioral, Cognitive Tests)
8.1.5 Laboratory-based Assays

8.2 By End-User

8.2.1 Veterinary Clinics
8.2.2 Animal Hospitals
8.2.3 Veterinary Diagnostic Laboratories
8.2.4 Research Institutions
8.2.5 Pet Owners
8.2.6 Others

8.3 By Animal Type

8.3.1 Dogs
8.3.2 Cats
8.3.3 Horses
8.3.4 Exotic Pets
8.3.5 Livestock
8.3.6 Others

8.4 By Diagnostic Method

8.4.1 Blood Tests
8.4.2 Imaging Techniques (MRI, CT, X-ray)
8.4.3 Neurological Evaluations
8.4.4 Biopsy Procedures
8.4.5 Molecular Diagnostics
8.4.6 Others

8.5 By Distribution Channel

8.5.1 Direct Sales
8.5.2 Online Sales
8.5.3 Distributors
8.5.4 Veterinary Conferences and Trade Shows
8.5.5 Others

8.6 By Region

8.6.1 Central Region
8.6.2 Eastern Region
8.6.3 Western Region
8.6.4 Southern Region

8.7 By Policy Support

8.7.1 Government Subsidies
8.7.2 Tax Incentives
8.7.3 Research Grants
8.7.4 Regulatory Support
8.7.5 Others

9. KSA Veterinary Neurodegenerative Disease Diagnostics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (KSA Veterinary Diagnostics Segment)
9.2.4 Market Penetration Rate (KSA, by Diagnostic Modality)
9.2.5 Number of Veterinary Diagnostic Tests Offered (Neurodegenerative Focus)
9.2.6 R&D Investment as % of Revenue
9.2.7 Product Innovation Rate (New Launches/Year)
9.2.8 Distribution Network Coverage (KSA Regions)
9.2.9 Regulatory Approvals in KSA (MOA/SFDA)
9.2.10 Customer Satisfaction Score (Veterinary Segment)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 IDEXX Laboratories, Inc.
9.5.2 Zoetis Inc.
9.5.3 Neogen Corporation
9.5.4 Virbac S.A.
9.5.5 Heska Corporation
9.5.6 Vetoquinol S.A.
9.5.7 Abaxis (a Zoetis company)
9.5.8 Elanco Animal Health Incorporated
9.5.9 Boehringer Ingelheim Animal Health
9.5.10 Antech Diagnostics, Inc.
9.5.11 PetDx
9.5.12 ACUVET Biotech
9.5.13 Avacta Animal Health Limited
9.5.14 National Veterinary Diagnostic Laboratory (Saudi Arabia)
9.5.15 Life Diagnostics, Inc.

10. KSA Veterinary Neurodegenerative Disease Diagnostics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Veterinary Services
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers and Vendors
10.1.4 Evaluation Criteria for Procurement

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Veterinary Facilities
10.2.2 Spending on Diagnostic Equipment
10.2.3 Budget for Research and Development
10.2.4 Expenditure on Training and Development

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges Faced by Veterinary Clinics
10.3.2 Issues in Animal Hospitals
10.3.3 Concerns of Pet Owners
10.3.4 Needs of Research Institutions

10.4 User Readiness for Adoption

10.4.1 Awareness of Diagnostic Options
10.4.2 Willingness to Invest in Advanced Diagnostics
10.4.3 Training Needs for Veterinary Staff
10.4.4 Adoption of New Technologies

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Diagnostic Effectiveness
10.5.2 Expansion of Services Offered
10.5.3 Customer Feedback and Improvement
10.5.4 Long-term Financial Benefits

11. KSA Veterinary Neurodegenerative Disease Diagnostics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of veterinary health reports and publications from KSA's Ministry of Environment, Water and Agriculture
  • Review of academic journals and articles focusing on neurodegenerative diseases in animals
  • Compilation of market data from industry associations and veterinary diagnostic laboratories in KSA

Primary Research

  • Interviews with veterinarians specializing in neurology and neurodegenerative diseases
  • Surveys conducted with veterinary diagnostic labs to understand testing capabilities and market needs
  • Focus groups with pet owners to gauge awareness and demand for neurodegenerative disease diagnostics

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and industry reports
  • Triangulation of data from veterinary clinics, diagnostic labs, and academic research
  • Sanity checks through feedback from a panel of veterinary experts and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on the number of pets and livestock in KSA
  • Segmentation of the market by types of neurodegenerative diseases and diagnostic methods
  • Incorporation of government initiatives and funding for veterinary health research

Bottom-up Modeling

  • Collection of data on diagnostic test prices and volumes from leading veterinary labs
  • Estimation of market share based on the number of veterinary practices offering neurodiagnostic services
  • Volume x price analysis to derive revenue estimates for each diagnostic category

Forecasting & Scenario Analysis

  • Multi-factor regression analysis considering pet ownership trends and veterinary spending
  • Scenario modeling based on potential regulatory changes and advancements in diagnostic technologies
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Clinics60Veterinarians, Clinic Managers
Diagnostic Laboratories40Lab Directors, Technical Managers
Pet Owners100Pet Owners, Animal Welfare Advocates
Academic Institutions50Veterinary Researchers, Professors
Government Agencies40Policy Makers, Veterinary Health Officials

Frequently Asked Questions

What is the current value of the KSA Veterinary Neurodegenerative Disease Diagnostics Market?

The KSA Veterinary Neurodegenerative Disease Diagnostics Market is valued at approximately USD 6 million, reflecting its specialized role within the broader Saudi veterinary diagnostics market, which exceeds USD 125 million.

What factors are driving growth in the KSA Veterinary Neurodegenerative Disease Diagnostics Market?

Which cities are leading in the KSA Veterinary Neurodegenerative Disease Diagnostics Market?

What regulations impact the KSA Veterinary Neurodegenerative Disease Diagnostics Market?

Other Regional/Country Reports

Oman veterinary neurodegenerative disease diagnostics market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Indonesia Veterinary Neurodegenerative Disease Diagnostics Market

Malaysia Veterinary Neurodegenerative Disease Diagnostics Market

APAC Veterinary Neurodegenerative Disease Diagnostics Market

SEA Veterinary Neurodegenerative Disease Diagnostics Market

Vietnam Veterinary Neurodegenerative Disease Diagnostics Market

Other Adjacent Reports

Kuwait Veterinary Imaging Market

Egypt Veterinary Biomarker Testing Market

Bahrain Veterinary Genetic Testing Market

Vietnam Veterinary Neurological Assessments Market

Philippines Veterinary Laboratory Assays Market

Malaysia Animal Health Pharmaceuticals Market

KSA Pet Healthcare Services Market

KSA Veterinary Diagnostic Laboratories Market

Belgium Animal Nutrition Supplements Market

Middle East Pet Insurance Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022